HPLC-PDA analysis of ACE-inhibitors, hydrochlorothiazide and indapamide utilizing design of experiments
Authors:
- Eyad Rashed DawudEDEyad Rashed Dawud
- Ashok K. ShakyaAshok K. Shakya
Open Access
- 1 July 2019
- journal article
- research article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 12 (5) , 718-728
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tabletChemical Industry and Chemical Engineering Quarterly, 2012
- Expanding the term “Design Space” in high performance liquid chromatography (I)Journal of Pharmaceutical and Biomedical Analysis, 2011
- Analysis of the angiotensin-converting enzyme inhibitors perindopril, lisinopril, and quinapril by HPLCPharmaceutical Chemistry Journal, 2011
- Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometryTalanta, 2011
- The use of experimental design in the development of an HPLC–ECD method for the analysis of captoprilTalanta, 2011
- Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme InhibitorCirculation, 2007
- Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulationJournal of Pharmaceutical and Biomedical Analysis, 2005
- Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulationsIl Farmaco, 2003
- Selected major risk factors and global and regional burden of diseaseThe Lancet, 2002
- A liquid chromatographic lon-pairing method for simultaneous determination of benazepril hydrochloride, fosinopril sodium, ramipril and hydrochlorothiazide in pharmaceutical formulationsChromatographia, 2001